After years of research and a lengthy regulatory approval process, Genus Pig Improvement Company (PIC) has received clearance from the U.S. Food and Drug Administration (FDA) for the gene edited PRRS-resistant pig (PRP) to be used in the U.S. food supply chain. Genus executives note this is a significant step toward commercialization in the U.S., however, approvals are still needed in key U.S. export markets, such as Mexico, Canada and Japan. The firm says it continues to make progress with regulators in these jurisdictions as well as with other international regulators, including China, Brazil, Colombia and, most recently, the Dominican Republic, where positive determinations for the PRRS-resistant pig have been approved. Colombia was the...
Key Market Insights The broad market is locked in on this week’s Trump-Xi meeting in Beijing, but this is no longer just a trade summit. Increasingly, the meeting is becoming tied directly to Iran, energy security, and the growing global economic fallout from disruptions through the Strai...
Illuminating the value of technical research
On behalf of a commodity producer organization, WPI evaluated the outputs from a project that featured a $5 million investment into technical research over multiple years. WPI’s team captured the results of this extensive effort and synthesized them for presentation to the organization’s governing board; among the findings uncovered and presented for the first time was the development of genomic traits proven, via rigorous testing, to provide crop yield advantages of 50 percent or more to U.S. farmers in times of drought. Capturing measurable results from long-term efforts can be challenging. Educating clients on the dynamics of success measurement when quantifiable results are not readily available requires deep client-consultant collaboration and an ability to consider both near- and long-term client aspirations with market/policy dynamics – attributes that WPI brings to every consulting engagement.